Wen-Hsin Huang
National Defense Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Wen-Hsin Huang.
Bioscience, Biotechnology, and Biochemistry | 2006
Wen-Hsin Huang; An-Rong Lee; Ching-Huey Yang
The active ingredients of ‘golden root’ of Scutellaria baicalensis GEORGI (Huang-Qin), a valuable traditional Chinese medicine, are polyhydroxyflavonoids, namely baicalein, oroxylin A and wogonin. With the objective of overcoming their poor solubility and to investigate their structure and activity relationships, baicaleinyl 7-O-sulfate was prepared, and extensive comparative antioxidative and anti-inflammatory tests were conducted. All the polyhydroxyflavonoids exhibited significant antioxidative and free-radical scavenging activities. In respect of their nitric oxide (NO) inhibition, wogonin was superior to all the other flavonoids, while oroxylin A was most potent in the inhibition of lipid peroxidation. Wogonin proved to be the most potent (82.9% inhibition, p<0.05) in its anti-inflammatory activity against carrageenan-induced rat hind paw edema. There was a correlation between the in-vivo anti-inflammatory activity and the in-vitro antioxidative activities.
Journal of Pharmacy and Pharmacology | 2005
Wen-Hsin Huang; An-Rong Lee; Pei-Yu Chien; Tz-Chong Chou
The direct acylation of trimethoxyphenol (1) with substituted cinnamoyl chlorides followed by Fries rearrangement and cyclization afforded a practical route for the synthesis of novel baicalein derivatives 4 functionalized on the B‐ring in good overall yields. In the methylthiazoletetrazolium bromide (MTT) assay, none of the synthetic polyhydroxyflavonoids were cytotoxic at concentrations up to 200 μm on lipopolysaccharide (LPS)‐activated murine RAW 264.7 macrophages over 24 h, while in the same cells they significantly inhibited NO production. Among the derivatives, 4d (IC50 = 46.1 ± 0.3 μm) was found to exhibit the most potent activity compared with N‐nitro‐L‐arginine methyl ester (L‐NAME, IC50 > 300 μm). Compounds 4b, 4e, 4f, 4h and 4i remarkably inhibited platelet aggregation induced by arachidonic acid and collagen in rabbit washed platelets compared with aspirin. Analysis of their structure‐activity relationships indicated that, in the structural modification on the B‐ring of baicalein (4a), introduction of appropriate electro‐withdrawing substituents such as 2‐CI (4b), 4‐CI (4d), and 4‐phenyl (4i) notably increased the potency on the inhibition of LPS‐activated NO production and arachidonic acid‐ and collagen‐induced aggregation. Baicalein itself was equally effective in the inhibition of LPS‐activated NO production and collagen‐induced aggregation but less active against arachidonic acid‐induced aggregation. Our in‐vitro results suggested that by appropriate structural modification of baicalein it may be possible to develop novel therapeutic agents against platelet‐aggregation and inflammation.
Journal of Pharmacy and Pharmacology | 1995
An-Rong Lee; Wen-Hsin Huang
Two new zinc sulphadiazine (Zn(SD)2)‐amine complexes, zinc sulphadiazine‐methylamine (Zn(SD)2(CH3NH2)2) and zinc sulphadiazine‐ethylenediamine (Zn(SD)2(C2H8N2)3·H2O), were prepared and compared with silver sulphadiazine (AgSD). The compounds were readily obtained by reaction of zinc nitrate hexahydrate with sulphadiazine or its salt in methylamine and ethylenediamine, respectively.
The Chinese Pharmaceutical Journal | 2003
Wen-Hsin Huang; Ching-Huey Yang; Pei-Yu Chien; An-Rong Lee
Approaches towards the preparation of 5,6,7-trimethoxyflavone (8), a key intermediate for the synthesis of baicalein, are discussed. Of the synthetic routes, the most efficient was accomplished by direct Fries acylation of trimethoxyphenol (1) with cinnamoyl chloride followed by oxidative cyclization of the resulting chalcone 6 with I 2 /DMSO in good overall yields (70%). Demethylation of 8 using 47% HBr/AcOH readily produced baicalein. The chalcone 6 could also be prepared by Claisen-Schmidt condensation of acetophenone 2 with benzaldehyde catalyzed in alkali.
Chemistry & Biodiversity | 2015
Shu-Ting Chung; Yi-Ting Huang; Hsin-Yi Hsiung; Wen-Hsin Huang; Chen-Wen Yao; An-Rong Lee
A series of novel isoflavonoids were synthesized based on structural modifications of daidzein, an active ingredient of traditional Chinese medicine (TCM) and evaluated for their anti‐influenza activity, in vitro, against H1N1 Tamiflu‐resistant (H1N1 TR) virus in the MDCK cell line. Among them, 4‐oxo‐4H‐1‐benzopyran‐8‐carbaldehydes 11a–11g were most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent. 3‐(4‐Bromophenyl)‐7‐hydroxy‐4‐oxo‐4H‐1‐benzopyran‐8‐carboxaldehyde (11c) displayed the best inhibitory activity (EC50, 29.0 μM) and selectivity index (SI>10.3). Analysis of the structureactivity relationships (SAR) indicated that both the non‐naturally‐occurring Br‐substituted B‐ring and appropriate CHO and OH groups on the A‐ring might be critical for the activity and selectivity against H1N1 TR influenza viruses.
Chemical & Pharmaceutical Bulletin | 2003
Wen-Hsin Huang; Pei-Yu Chien; Ching-Huey Yang; An-Rong Lee
European Journal of Pharmacology | 2006
Shiou-Chi Cherng; Wen-Hsin Huang; Chia-Yang Shiau; An-Rong Lee; Tz-Chong Chou
Research on Chemical Intermediates | 2016
Shu-Ting Chung; Wen-Hsin Huang; Chih-Kuo Huang; Feng-Cheng Liu; Ren-Yeong Huang; Chin-Chen Wu; An-Rong Lee
Chemical & Pharmaceutical Bulletin | 2014
Shu-Ting Chung; Pei-Yu Chien; Wen-Hsin Huang; Chen-Wen Yao; An-Rong Lee
Archive | 2013
An-Rong Lee; Chi-Hong Chu; Wen-Liang Chang; Chen-Wen Yao; Wen-Hsin Huang; Li-Heng Pao